WO2005084654A3 - Procedes et compositions pour le traitement ou la prevention de troubles psychiatriques avec des inhibiteurs de cox-2 seuls et en combinaison avec des antidepresseurs - Google Patents
Procedes et compositions pour le traitement ou la prevention de troubles psychiatriques avec des inhibiteurs de cox-2 seuls et en combinaison avec des antidepresseurs Download PDFInfo
- Publication number
- WO2005084654A3 WO2005084654A3 PCT/US2005/006818 US2005006818W WO2005084654A3 WO 2005084654 A3 WO2005084654 A3 WO 2005084654A3 US 2005006818 W US2005006818 W US 2005006818W WO 2005084654 A3 WO2005084654 A3 WO 2005084654A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- cox
- treating
- combination
- psychiatric disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05724377A EP1725222A2 (fr) | 2004-03-02 | 2005-03-02 | Procedes et compositions pour le traitement ou la prevention de troubles psychiatriques avec des inhibiteurs de cox-2 seuls et en combinaison avec des antidepresseurs |
BRPI0508254-4A BRPI0508254A (pt) | 2004-03-02 | 2005-03-02 | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos |
JP2007501959A JP2007526328A (ja) | 2004-03-02 | 2005-03-02 | 単独および抗うつ薬と組み合わせた形のCox−2阻害剤によって精神障害を治療または予防するための方法および組成物 |
CA002556380A CA2556380A1 (fr) | 2004-03-02 | 2005-03-02 | Procedes et compositions pour le traitement ou la prevention de troubles psychiatriques avec des inhibiteurs de cox-2 seuls et en combinaison avec des antidepresseurs |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54928104P | 2004-03-02 | 2004-03-02 | |
US60/549,281 | 2004-03-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005084654A2 WO2005084654A2 (fr) | 2005-09-15 |
WO2005084654A3 true WO2005084654A3 (fr) | 2005-11-17 |
Family
ID=34919463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/006818 WO2005084654A2 (fr) | 2004-03-02 | 2005-03-02 | Procedes et compositions pour le traitement ou la prevention de troubles psychiatriques avec des inhibiteurs de cox-2 seuls et en combinaison avec des antidepresseurs |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1725222A2 (fr) |
JP (1) | JP2007526328A (fr) |
BR (1) | BRPI0508254A (fr) |
CA (1) | CA2556380A1 (fr) |
WO (1) | WO2005084654A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005293552B2 (en) * | 2004-10-15 | 2011-04-14 | Msd Oss B.V. | Treatment of bipolar disorders and associated symptoms |
WO2007076875A2 (fr) * | 2006-01-06 | 2007-07-12 | Aarhus Universitet | Composes agissant sur le transporteur de la serotonine |
DE502007002185D1 (de) * | 2006-04-04 | 2010-01-14 | Emodys Gmbh | Verwendung von zusammensetzungen enthaltend kappa-opioidrezeptor-antagonisten zur behandlung von dissoziativen störungen |
JP5643103B2 (ja) * | 2007-11-28 | 2014-12-17 | ウェルズ ファーゴ バンク ナショナル アソシエイション | オリゴマー−三環物質コンジュゲート |
FR2935611B1 (fr) * | 2008-09-10 | 2010-10-15 | Commissariat Energie Atomique | Utilisation d'agents anti-connexines pour moduler l'effet therapeutique de molecules psychotropes |
US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
GB0822077D0 (en) * | 2008-12-03 | 2009-01-07 | Minster Res Ltd | Novel treatments |
MX2014004566A (es) * | 2011-10-18 | 2014-07-09 | Raqualia Pharma Inc | Composicion farmaceutica. |
WO2013179153A1 (fr) * | 2012-05-10 | 2013-12-05 | Mahesh Kandula | Compositions et méthodes de traitement de troubles neurologiques dégénératifs et de maladies neurologiques |
GB201416017D0 (en) * | 2014-09-10 | 2014-10-22 | New Royal Holloway & Bedford | An Anticonvulsant Compound |
CA3026783A1 (fr) * | 2016-06-07 | 2017-12-14 | Akhil MEHRA | Methodes et compositions pour le traitement de maladies et de troubles lies a des traumatismes ou a des facteurs de stress |
BR112019012573A2 (pt) | 2016-12-20 | 2019-11-19 | Lts Lohmann Therapie Systeme Ag | sistema terapêutico transdérmico que contém asenapina e polissiloxano ou poli-isobutileno |
WO2018115001A1 (fr) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Système thérapeutique transdermique comportant de l'asénapine |
ES2881783T3 (es) | 2017-06-26 | 2021-11-30 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona |
BR112019028034A2 (pt) * | 2017-06-30 | 2020-07-07 | Chase Therapeutics Corporation | composições de antagonista de nk-1 e métodos para uso no tratamento da depressão |
WO2019060729A1 (fr) * | 2017-09-21 | 2019-03-28 | Tremeau Pharmaceutials, Inc. | Produit pouvant être ingéré et procédé d'utilisation associé |
JP2021505595A (ja) | 2017-12-05 | 2021-02-18 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 結晶形およびその製造方法 |
MX2020005518A (es) * | 2017-12-05 | 2020-11-06 | Sunovion Pharmaceuticals Inc | Mezclas no racemicas y usos de las mismas. |
CN112704672A (zh) | 2018-06-20 | 2021-04-27 | 罗曼治疗***股份公司 | 含有阿塞那平的透皮治疗*** |
JP2022535893A (ja) | 2019-06-04 | 2022-08-10 | サノビオン ファーマシューティカルズ インク | 放出調節製剤およびその使用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102297A2 (fr) * | 2001-06-19 | 2002-12-27 | Mueller Norbert | Utilisation d'inhibiteurs de cyclo-oxygenase-2 pour le traitement de la schizophrenie, de troubles delirants, de troubles affectifs, de l'autisme ou de tics |
-
2005
- 2005-03-02 WO PCT/US2005/006818 patent/WO2005084654A2/fr not_active Application Discontinuation
- 2005-03-02 EP EP05724377A patent/EP1725222A2/fr not_active Withdrawn
- 2005-03-02 CA CA002556380A patent/CA2556380A1/fr not_active Abandoned
- 2005-03-02 JP JP2007501959A patent/JP2007526328A/ja not_active Withdrawn
- 2005-03-02 BR BRPI0508254-4A patent/BRPI0508254A/pt not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102297A2 (fr) * | 2001-06-19 | 2002-12-27 | Mueller Norbert | Utilisation d'inhibiteurs de cyclo-oxygenase-2 pour le traitement de la schizophrenie, de troubles delirants, de troubles affectifs, de l'autisme ou de tics |
Non-Patent Citations (1)
Title |
---|
TAVARES I A ET AL: "ACEMETACIN AND INDOMETHACIN: DIFFERENTIAL INHIBITION OF CONSTITUTIVE AND INDUCIBLE CYCLO-OXYGENASES IN HUMAN GASTRIC MUCOSA AND LEUCOCYTES", INTERNATIONAL JOURNAL OF TISSUE REACTIONS, BIOSCIENCE EDIPRINT, GENEVA, CH, vol. 15, no. 2, 1993, pages 49 - 53, XP000655243, ISSN: 0250-0868 * |
Also Published As
Publication number | Publication date |
---|---|
EP1725222A2 (fr) | 2006-11-29 |
WO2005084654A2 (fr) | 2005-09-15 |
JP2007526328A (ja) | 2007-09-13 |
CA2556380A1 (fr) | 2005-09-15 |
BRPI0508254A (pt) | 2007-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005084654A3 (fr) | Procedes et compositions pour le traitement ou la prevention de troubles psychiatriques avec des inhibiteurs de cox-2 seuls et en combinaison avec des antidepresseurs | |
WO2005037259A3 (fr) | Procedes et compositions de prevention ou de traitement de neoplasie comprenant un inhibiteur de la cox-2 en combinaison avec un antagoniste recepteur du facteur de croissance epidermale | |
WO2007089445A3 (fr) | Combinaisons d'inhibiteurs d'ang2 et de vegf | |
WO2006073973A3 (fr) | Nouveaux dérivés de benzylamine en tant qu'inhibiteurs de cetp | |
WO2005086656A3 (fr) | Derives d'heteroarylaminopyrazole utilises pour traiter le diabete | |
WO2007106537A3 (fr) | Aminoquinolones utilisées comme inhibiteurs de la gsk-3 | |
WO2005105780A3 (fr) | Compositions utiles en tant qu'inhibiteurs de la rock et d'autres proteines kinases | |
CY1112238T1 (el) | Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων | |
WO2007092622A3 (fr) | Compositions et méthodes pour le traitement d'os | |
WO2007059230A3 (fr) | 1h-benzimidazole-4-carboxamides substitues efficaces en tant qu’inhibiteurs de parp | |
WO2006028963A3 (fr) | Composes heterocycliques substitues et leurs utilisations | |
WO2007059154A3 (fr) | Traitement de cancers a resistance acquise a des inhibiteurs de kit | |
WO2007050793A3 (fr) | Methodes et compositions de traitement du syndrome de marfan et de troubles associes | |
WO2006026747A3 (fr) | Composes de diphenylethylene et leurs utilisations | |
WO2004017948A8 (fr) | Utilisation d'inhibiteur lck pour le traitement d'affections immunologiques | |
WO2005023193A3 (fr) | Methodes permettant de traiter l'endometriose | |
WO2006028524A3 (fr) | Compositions et traitements pour l'inhibition de kinase et/ou de hmg-coa reductase | |
WO2006080549A3 (fr) | Procede et composition de traitement de troubles du systeme nerveux central | |
WO2004043456A8 (fr) | Inhibiteurs d'absorption du cholesterol pour le traitement de la demyelination | |
WO2007044325A3 (fr) | Inhibiteurs de l'interaction du domaine apoe4 et methodes d'utilisation | |
TW200507840A (en) | Method of treating multiple myeloma | |
EA200970164A1 (ru) | Ингибиторы каспазы на основе пиридазинонового каркаса | |
WO2006130493A3 (fr) | Heterocycles utiles comme modulateurs de canaux ioniques | |
WO2005112923A3 (fr) | Dérivés de 5-anilino-4-hétéroarylpyrazole utiles pour le traitement du diabete | |
TW200716561A (en) | P38 inhibitors and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2556380 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/009919 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007501959 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005724377 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005724377 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0508254 Country of ref document: BR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2005724377 Country of ref document: EP |